Self-adjusting insulin proves promising for type 1 diabetics

Type 1 diabetics must constantly control their blood glucose with insulin. It’s a Goldilocks-type situation: administer too much insulin, and they risk low blood glucose (hypoglycemia), while too little can lead to high blood glucose (hyperglycemia). Researchers have developed a self-adjusting nanoparticle-based insulin formulation that may go some way towards improving blood glucose control.